{
  "retracted": false,
  "timestamp": 1472688000000,
  "updates": [
    {
      "timestamp": 1495739791922,
      "identifier": {
        "doi": "10.1016/j.dld.2016.06.015"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.dld.2015.12.016"
  },
  "journal": "Digestive and Liver Disease",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” [Dig. Liver Dis. 48 (2016) 360–370]"
}
